Fig. 6
a After injecting C57BL6 mouse-derived bone marrow cells into irradiated BDF1 mice, P815 cells were transplanted subcutaneously 8 days later. Decitabine was injected on days 1–5 after tumor transplantation, and donor lymphocyte infusion (DLI) was performed the day after injection. Changes observed in b survival, c tumor size, d body weight, and e GVHD scoring depending on the delay in DLIs. The experiment was conducted in 3 times. *P < 0.05 for control vs. DEC-treated group